Company · Oakville, Ontario, Canada
Valeo Pharma Inc.
Everything this company holds in Health Canada’s product databases, as the company’s name is spelled there.
- Drug products (DIN)
- 15
- 4 authorized now
- Natural health products
- 2
- 1 active licences
- Medical device licences
- 0
- 0 active
- Notices of Compliance
- 15
Drug products
Authorized products first.
| Name | DIN | Status | Status since |
|---|---|---|---|
| AMETOP GEL 4% | 02230575 | Marketed | |
| ONSTRYV | 02484641 | Marketed | |
| ONSTRYV | 02484668 | Marketed | |
| YONDELIS | 02351528 | Marketed | |
| ACETOXYL 10 GEL | 00406848 | Cancelled Post Market | |
| ACETOXYL 2.5 GEL | 00406813 | Cancelled Post Market | |
| ACETOXYL 5 GEL | 00406821 | Cancelled Post Market | |
| ALLERJECT | 02382059 | Cancelled Post Market | |
| ALLERJECT | 02382067 | Cancelled Post Market | |
| ARISTOSPAN | 02194155 | Cancelled Post Market | |
| COPHYLAC EXPECTORANT DROPS | 02224585 | Cancelled Post Market | |
| DAN-TAR PLUS SHAMPOO | 00550434 | Cancelled Post Market | |
| OXIZOLE | 02230452 | Cancelled Post Market | |
| VAL-PAMIDRONATE DISODIUM | 02382032 | Cancelled Post Market | |
| ZNP BAR 2% | 00752177 | Cancelled Post Market |
Natural health products
Active licences first, newest first.
| Name | NPN | Status | Licensed |
|---|---|---|---|
| HESPERCO | 80103882 | Active | |
| Hydrosal Gel | 80002655 | Discontinued |
Notices of Compliance
Newest first.
- ONSTRYVDecember 18, 2020 · NOC 24837 · Supplement to a New Drug Submission (SNDS)
- YONDELISJune 2, 2020 · NOC 23705 · New Drug Submission (NDS)
- ONSTRYVApril 29, 2020 · NOC 23531 · Supplement to a New Drug Submission (SNDS)
- ONSTRYVFebruary 25, 2020 · NOC 23251 · Supplement to a New Drug Submission (SNDS)
- ONSTRYVJanuary 10, 2019 · NOC 21720 · New Drug Submission (NDS)
- VAL-ZOLEDRONIC ACIDNovember 24, 2014 · NOC 16338 · Abbreviated New Drug Submission (ANDS)
- VPI-BACLOFEN INTRATHECALOctober 10, 2013 · NOC 14800 · Abbreviated New Drug Submission (ANDS)
- PROPADERMJuly 3, 2013 · NOC 14513 · New Drug Submission (NDS)
- VAL-PAMIDRONATE DISODIUMApril 23, 2012 · NOC 13213 · Abbreviated New Drug Submission (ANDS)
- VAL-VANCOMYCINAugust 11, 2011 · NOC 12558 · Supplement to an Abbreviated New Drug Submission (SANDS)
- VAL-VANCOFebruary 24, 2010 · NOC 11088 · Abbreviated New Drug Submission (ANDS)
- SYNALAR SOLUTION 0.01%; SYNALAR OINTMENT 0.025%June 24, 2009 · NOC 10292 · New Drug Submission (NDS)
- ALPROSTADIL INJECTION USPJune 10, 2008 · NOC 9605 · Abbreviated New Drug Submission (ANDS)
- CLINDA-TSeptember 12, 2006 · NOC 8257 · Abbreviated New Drug Submission (ANDS)
- OXIZOLE CREAM 1%January 23, 2004 · NOC 133 · New Drug Submission (NDS)
Recalls and safety alerts that mention its products
Health Canada’s recall notices do not carry licence numbers, so these are matched by name. A notice may cover another product or only some lots: read it to see what it covers.
- Allerject 0.3 mg / 0.3 mL (2015-10-28)October 28, 2015 · Drugs · Product safety · Type I
- Allerject 0.15 mg / 0.15 mL (2015-10-28)October 28, 2015 · Drugs · Product safety · Type I
- Allerject (2015-06-13)June 16, 2015 · Drugs · Product safety · Type I
- Two Lots of Allerject (0.15 mg / 0.15mL auto-injector) For Use In Children Recalled Due to Manufacturing DefectJune 13, 2015 · Drugs